Needle breast biopsy system and method of use

Information

  • Patent Grant
  • 11701199
  • Patent Number
    11,701,199
  • Date Filed
    Wednesday, March 4, 2020
    4 years ago
  • Date Issued
    Tuesday, July 18, 2023
    10 months ago
Abstract
A tilted needle biopsy assembly is provided for mounting on an x-ray system. Because the biopsy needle is angled relative to at least one of the detector and the x-ray source, x-ray imaging may be performed during the biopsy procedure without interference by the biopsy device. The angled biopsy needle additionally allows improved access to the axilla and chest wall of the patient. The stereotactic biopsy device of the present invention may be coupled to any x-ray system, whether upright or prone, including but not limited to mammography systems, tomosynthesis systems, and combination mammography/tomosynthesis systems. The system flexibly supports the use of any mode of image capture (i.e., scout, two dimensional mammogram, three-dimensional reconstructed volume) for either or both target visualization and target localization. With such an arrangement, a needle biopsy assembly having improved patient coverage is provided for use with a variety of different x-ray imaging platforms.
Description
BACKGROUND OF THE INVENTION

Mammography is a well-established method of breast imaging which may be used for breast cancer screening and diagnosis. Screening mammograms are preferably obtained annually for female members of the population over the age of forty, or those having a genetic risk of breast cancer. Should masses or calcifications (‘regions of interest’) be identified during a screening mammogram, the patient may require further diagnosis. Such diagnosis may involve biopsying the region of interest and analyzing excised tissue.


Various imaging modalities have historically been used during breast biopsies. The imaging modalities include ultrasound imaging, x-ray imaging and magnetic resonance imaging. Performing a breast biopsy typically involves positioning the patient, visualizing the region of interest using the imaging equipment, targeting coordinates of the region and retrieving cells or tissue from the targeted region. Cells or tissue may be retrieved in a variety of ways, including through open surgery, fine needle aspiration, core needle biopsy or vacuum assisted biopsy. Open surgery, the most invasive procedure, is generally performed by a radiologist placing a wire into the breast during visualization of the region of interest, where the wire extends into the region that is to be excised. The patient is then transferred to surgery and tissue is retrieved using the wire to locate the region of interest.


Fine needle aspiration, core needle biopsies and vacuum assisted biopsies are less invasive than open surgery, allowing cells and tissue to be obtained without the need for open surgery. All are needle biopsies, with the size of the needle, and thus the corresponding size (and number) of the biopsied samples, being differentiators. In each procedure the patient is positioned, the region of interest is visualized, the needle of the biopsy device is advanced to the target region of interest and the tissue is retrieved. Fine needle aspiration and core needle biopsy devices typically retrieve one tissue sample and their advancement to the target may be monitored using an imaging modality such as ultrasound. Vacuum assisted biopsy devices generally have larger needles and can extract multiple cores.


X-ray imaging in stereotactic mode is generally used for breast biopsies because it is desirable to visualize and target regions in a three dimensional volume. Stereotactic biopsies obtain volume information using x-ray images taken in at least two planes. The x-ray images are then processed to localize a target region of interest in three-dimensional space using the principal of parallax to determine the depth, or Z dimension, of the target region.


U.S. Patent Application 2008/0045833, filed Feb. 21, 2008 and incorporated herein by reference, describes systems and methods for using tomosynthesis for lesion localization during breast biopsy. Tomosynthesis (tomo) is a method of performing three dimensional (3D) breast x-ray imaging. It generates images of cross sectional slices through a compressed breast, and also is used to identify breast pathologies. One of the advantages of tomosynthesis is that the images are three-dimensional so that once an area of interest is identified in an image its exact 3D coordinate in the breast can be calculated or estimated, e.g. from the x, y coordinate in the image of a slice and from the z, or depth, coordinate given by the image slice depth location. Another advantage of tomosynthesis is its ability to provide high contrast visibility of objects by the suppression of images from objects at different heights in the breast. Because of its superior contrast visibility, it is expected that there will be pathologies seen on the tomo images that will not be visible using standard x-ray mammography, stereotactic devices, ultrasound or even MRI. For this reason, it is desired to develop localization methods using tomosynthesis systems that utilize tomosynthesis' natural 3D localization abilities.


SUMMARY OF THE INVENTION

According to one aspect of the invention a stereotactic needle biopsy assembly is provided for mounting between an x-ray source and a detector of an x-ray imaging system. The stereotactic assembly includes a mounting arm for supporting a biopsy device at an angle offset from normal to a plane of defined by the detector. In some embodiments, the assembly may also include a lateral side arm permitting lateral access to the breast. The stereotactic needle biopsy assembly includes a guidance module for motorized guidance of the biopsy device to a target location during a biopsy for excising tissue. Because the biopsy needle is angled relative to the detector, x-ray imaging may be performed during the biopsy procedure without interference by the biopsy device. In addition the angled biopsy needle allows improved access to the axilla and chest wall of the patient.


In one embodiment the needle biopsy assembly includes a motor or equivalent mechanism enabling automatic advancement of the biopsy device towards an identified biopsy target location. The system advantageously additionally includes mechanisms enabling manual advancement of the device. The system permits the user to define stop locations along the biopsy path to the target, for transitioning between automated and manual control.


In one embodiment the needle biopsy assembly may include a control module, mounted on the needle biopsy assembly, the control module enabling the medical personnel to control the automated movement of the device towards the target without leaving the patient. The control module in some embodiments may display information related to the biopsy procedure, such as the relative locations of the needle and the target. The control module may also provide visible or audible warnings to the user, for example to warn of proximity of the needle to the chest wall, the breast platform, or other undesirable position. In one embodiment the control buttons of the control module are arranged to preclude unintended advancement of the biopsy device.


The stereotactic biopsy device of the present invention may be coupled to any x-ray system, whether upright or prone, including but not limited to mammography systems, tomosynthesis systems, and combination mammography/tomosynthesis systems. The system flexibly supports the use of any mode of image capture (i.e., scout, two dimensional mammogram, three-dimensional reconstructed volume) and any combination of two dimensional or three dimensional image data for either or both target visualization and target localization. With such an arrangement, a needle biopsy assembly having improved patient coverage is provided for use with a variety of different x-ray imaging platforms.


In particular such an assembly may easily be integrated into a tomosynthesis imaging system. Such a tomosynthesis system could be readily adapted to provide automated stereotactic image capture for use with the needle biopsy assembly by capturing tomo projection images at desired stereotactic angles. Such a system has the added advantage of reducing patient exposure because tomosynthesis projection images are generally obtained at lower dose than conventional mammograms and therefore stereotactic volume information (for use in visualization or targeting) can be obtained at reduced dosage. These and other advantages will be described in further detail below.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 illustrates an x-ray imaging system which may advantageously incorporate the needle biopsy assembly of the present invention;



FIG. 2 illustrates one embodiment of the needle biopsy assembly of the present invention with a mounted biopsy device;



FIGS. 3A and 3B illustrates a portion of an x-ray system on which the needle biopsy assembly of the present invention is mounted and is used to illustrate how the angular tilt of the biopsy device reduces interference during x-ray imaging;



FIG. 4 is a side view of the needle biopsy assembly of the present invention, illustrating in more detail the angular tilt of the biopsy device support arm;



FIG. 5 is a top down view of the needle biopsy assembly of the present invention;



FIGS. 6A-6C illustrate compression paddles which may advantageously be used with the needle biopsy assembly of FIG. 2;



FIG. 7 is a side of a compression paddle which may be used with the needle biopsy assembly of the present invention;



FIG. 8 illustrates an image capture at the acquisition workstation interface, wherein the entire detector is visible through the radiolucent compression paddle;



FIG. 9 is a flow diagram illustrating exemplary steps that may be performed during a biopsy using the needle biopsy assembly of the present invention;



FIG. 10 illustrates an exemplary view of a user interface of the control unit of the needle biopsy assembly of FIG. 2;



FIG. 11 illustrates an exemplary view of a user interface of an acquisition work station including functional modules and displays supporting and related to the needle biopsy assembly of FIG. 2; and



FIGS. 12A-12C illustrate views of an embodiment of the needle biopsy assembly with a lateral biopsy arm attachment.





DETAILED DESCRIPTION

Breast tomosynthesis systems generally include an x-ray source mounted on a rotatable arm of a gantry and an x-ray detector positioned generally normal to the x-ray source when the x-ray source is at zero position. During tomosynthesis image acquisition, the x-ray source is rotated over a limited angular range. At various points in the x-ray source trajectory the source is activated and an image is captured by the detector. Each image captured at each point is referred to as a projection image. Computer programs are used to reconstruct a three dimensional volume from the projection images and the three dimensional volume is used for lesion detection. One example of an x-ray imaging system capable of mammographic and tomosynthesis imaging and which may be adapted to incorporate the present invention is shown in FIG. 1.


The mammography/tomosynthesis system is shown to include an acquisition work station (AWS) 4 and gantry 1 supporting an x-ray imaging assembly 2. Such a mammography/tomosynthesis system is currently available from the common assignee under the trade name Selenia Dimensions, and is representative of merely one x-ray system on which the needle biopsy assembly 10 of the present invention may be mounted. The gantry 1 supports a C-arm that can move up or down along the gantry to a selected height, driven by motor(s) controlled by a health professional operating the system. C-arm carries an x-ray tube 2a at an upper end and a breast tray 2b at a lower end. Tray 2b covers a flat panel x-ray image receptor 2c, spaced from the tray by a focused anti-scatter grid 2d (which may be retractable so that it can be removed from the space between tray 2b and receptor 2c). The C-arm also carries a compression paddle 2e that is between source 2a and breast tray 2b and is motorized to move away from tray 2b so a patient's breast can fit between tray 2b and paddle 2e, and closer to tray 2b so the patient's breast can be compressed and immobilized. The movement of paddle 2e is motorized and controlled by the health professional. Paddles 2e of different size and different configurations can be fitted on the gantry to suit different breast sizes or to suit imaging needs (i.e., for screening or diagnosis). In addition, the health professional can move paddle 2e along the width of tray 2b to a position in which paddle 2e matches the position of a breast that is not centered on tray 2b, as in the Selenia system currently offered by the common assignee. The system further includes other components, such as a control station 4 comprising interface devices such a keyboard 4a and trackball 4b, a display screen 4c, and control and image processing facilities.


According to one aspect of the invention a needle biopsy assembly 10 may easily be mounted in between the x-ray source and the x-ray detector of the imaging system 2. Unlike previous needle biopsy assemblies, the needle biopsy assembly of the present invention utilizes all of the existing components of the x-ray system, including the compression device and the x-ray detector. As a result, it can be appreciated that the needle biopsy assembly is a low cost solution which makes upright needle biopsy capability available to a variety of current x-ray imaging platforms.



FIG. 2 illustrates the needle biopsy assembly 10 in more detail. Support bracket 21 extends between handles 23a and 23b, which facilitate transport of the assembly. Guidance module 19, mounted on support bracket 21, includes components for controlling the movement of the biopsy device 15. The biopsy device may be, for example, an Eviva™ vacuum assisted biopsy device manufactured and sold by Hologic, Inc. Fixed support arm 17 extends from the guidance module to connector 31. In one embodiment connector 31 connects angular support arm 12 to the fixed support arm 17 at a fixed angle. Alternative embodiments which include adjustment mechanisms for varying the angle of displacement between the angular support arm and the fixed support arm may be substituted herein as equivalents. Holster mount 35 is moveably coupled to the support arm. The linear movement may be mechanically controlled (i.e., via the guidance module and associated motors) and/or may be manually controlled using either or both of the thumbwheel knobs 33a and 33b. The holster mount 35 includes an attachment mechanism 36 that is adapted to receive biopsy holster 13. The biopsy device 15 sits within the biopsy holster 13. A needle support 11 may advantageously be coupled to the holster mount for needle stabilization. A control module 25 may be mounted to either of the handles, 23b or 23a via clamp 36. In various embodiments, each handle may include one or more electrical connectors which enable communication between the clamped control module 25 and the guidance module 19, and the medical professional may move the control module to either handle as a matter of preference. The control module 25 includes a user interface that enables a medical professional to control the biopsy procedure without the need to leave the patient. The control module includes a display 28 for displaying a status or other information about the biopsy, and one or more buttons 27 for controlling the movement of the biopsy device during the procedure.



FIGS. 3A and 3B illustrate the needle biopsy assembly 10 mounted on a gantry of an x-ray imaging system. Various embodiments of the needle biopsy assembly may be used with either an upright or prone imaging system, for the purposes of this application an embodiment for use with an upright breast tomosynthesis imaging system (such as the Dimensions™ Breast Tomosynthesis imaging system provided by Hologic, Inc.) is described. An exemplary tomosynthesis imaging system may include a tube head 32 supporting a cone beam or other x-ray source, and a compression platform 30 encasing an x-ray detector. The tube head 32 is rotatably mounted on a gantry (not shown) to enable the tube head to rotate in along an angular trajectory generally designated by the dashed line 41 in FIG. 3B.


In one embodiment the needle biopsy assembly 10 includes clamps, hooks or other attachment means for mounting the needle biopsy assembly to the gantry of the tomosynthesis imaging system. Advantageously the clamps are mated to features of the gantry that support other attached devices (such as face shields and the like) although such reuse is not a requirement.


In the example of FIGS. 3A and 3B, the holster 13 is coupled to the holster mount on the a fixed angle arm 12, and the fixed angle arm 12 is fixedly mounted on the support arm 17 at an angle offset from normal by 10 degrees, although it is readily appreciated that the offset angle may vary and is largely a matter of design choice. Angling the arm 12 (and by consequence the biopsy device 15) allows the biopsy device to be advanced to a desired location within a biopsy target area (indicated generally by the target area 50) without the biopsy device and holster introducing artifacts into the x-ray image. As shown in FIG. 3B, the cone beam x-ray source will extend into the target area 50, but the device 15 does not fall within the cone beam. It should be noted that although a 10 degree fixed angle is disclosed, the present invention is not limited to any particular fixed angle and it is appreciated that the selected fixed angle may differ in response to particular geometries of the imaging systems and tissue removal tools. In a broadest sense, the present invention encompasses the idea of angling a biopsy needle to limit the introduction of visual artifacts caused by the needle during x-ray imaging.



FIG. 4 is a side view of an exemplary embodiment of a needle biopsy assembly of the present invention. In FIG. 4, line A is within a plane that is ‘normal’ to the plane of the x-ray detector 30. Line B illustrates the angular displacement of the biopsy device, and therefore the device is offset from the normal by an angular measure of 0. As a result the biopsy device will interfere with biopsy imaging.


Also shown in more detail in FIG. 4 are exemplary coupling mechanisms 50a and 50b of the needle biopsy assembly 10. The coupling mechanisms 50a and 50b are adapted to mate with complementary features of the gantry. Other types of coupling mechanisms, including latches, hooks, slots and the like may be readily substituted herein as equivalents.



FIG. 5 is a top down view of the exemplary embodiment of the needle biopsy assembly, shown with only a subset of components labeled for ease of reference. When viewing the needle biopsy assembly from this perspective, the displacement N of the needle tip which results from the angular tilt of the biopsy device is readily apparent. This view best illustrates the ability of this device to biopsy areas of the breast (such as the axilla tissue and tissue near the chest wall) which were previously difficult to access using prior art stereotactic devices.



FIGS. 6A through 6C illustrate various compression paddles which may be used with the present invention. In contrast to prior art needle biopsy compression paddles, which were generally fabricated of radio-opaque material having an opening therethrough for accepting the biopsy needle, the compression paddles 62A-62C are preferably radiolucent. Slots 64a and 64b are positioned to enable the compression paddle to be removably coupled to the compression device of the x-ray imaging system, allowing the paddles to easily be exchanged with the mammography/tomosynthesis paddles used for breast cancer screening. The biopsy compression paddles may be manufactured in different sizes to be used for different sized breasts, as shown in FIGS. 6B and 6C. An opening 66 is provided in each biopsy compression paddle. The opening enables the portion of the breast associated with the target to be exposed. As shown in FIG. 7, the portion 68 of the compression paddle 62a that surrounding the opening 66 is shaped to increase the compression on the portion of the breast being biopsied, thereby stabilizing the biopsied area.


One advantage of using the radiolucent breast compression paddle is that it allows full view of the detector; in prior art needle biopsy arrangement, only a portion of the detector associated with target localization was visible. This was sufficient because prior art biopsies were only performed on that portion of the tissue which was immediately below the opening in the compression paddle. However, the tilted needle of the present invention increases the amount of tissue that is available for biopsy beyond the border of the compression paddle opening—the needle in fact has the reach N shown in FIG. 5. Thus, as mentioned above, axilla tissue and tissue close to the chest wall can more readily be excised during biopsy.



FIG. 8 illustrates a 2D image of a breast taken with a radiolucent biopsy paddle such as those shown in FIGS. 6 and 7. As shown in FIG. 8, one advantage of the radiolucent compression paddle is that the entire detector image may be viewed at the acquisition workstation interface; the radiologist is no longer limited in their access to information. As a result, the radiologist may see that portions of a lesion 80 extend beyond the compression paddle opening 66. This portion of the breast can be accessed using the tilted biopsy needle assembly of the present invention to ensure that all tissue is accessed for proper diagnosis.


Exemplary needle biopsy assemblies such as that described above may be generally used as follows. A patient who has been identified as a candidate for biopsy is positioned at the x-ray imaging system. At step 91 the biopsy compression paddle moves down towards the compression platform, compressing the patient's breast, and the process of visualizing the lesion is initiated at step 92. As mentioned briefly above, depending upon the capabilities of the x-ray imaging system, visualization of the lesion may be performed using a scout image, a mammogram, acquired stereotactic images, acquired tomosynthesis projection images, tomosynthesis reconstructed images, or any combination thereof. In one embodiment, an x-ray imaging system having tomosynthesis capabilities may be adapted to include a ‘stereotactic mode’, which, when selected, causes the x-ray imaging system to automatically retrieve the typical+/−15 degree stereotactic images and performs appropriate imaging processing on the stereotactic images to derive a stereotactic volume. One advantage of such an embodiment is that patient exposure may be reduced in tomosynthesis systems which use lower doses during projection image acquisition.


Once the lesion has been visualized, at step 93 the lesion is targeted. Targeting the lesion involves identifying the coordinates of the lesion using image data, and converting the coordinates from the Cartesian coordinate system of the images to the angular coordinate system of the tilted biopsy assembly using conversion techniques known to those of skill in the art. According to one aspect of the invention, different images, or combinations of images, may be used for visualizing the lesion than are used for targeting the lesion. For example, assume that a scout image is initially used to ensure that the patient is in position, and a pair of stereotactic images are used to visualize the lesion. If the lesion is found in the scout image, but not in both stereo images, the scout may be used in combination with the stereotactic image in which the lesion is located to derive target location information. Therefore, as above, depending upon the capabilities of the x-ray imaging system, the lesion target coordinates may be derived using a scout image, a mammogram, acquired stereotactic images, acquired tomosynthesis projection images, tomosynthesis reconstructed images, or any combination thereof.


At step 94, once the target coordinates are derived the medical professional can being the biopsy procedure by pressing control buttons required to move the biopsy needle. FIG. 10 illustrates an exemplary display and buttons of a control unit 25. The control unit includes a display 28 for displaying information related to the biopsy, such as information regarding needle size, distance to platform and paddle, needle coordinates, target coordinates, proximity to target and other related information. The control panel may also provide other helpful information to the user, such as warning indicators when the needle is too close to the breast platform, chest wall or skin line. As mentioned above, the warning indicators may be color coded or may provide other visual or audible indicators of undesirable conditions.


As mentioned above, in one embodiment the control unit also includes buttons (including button 27) positioned and arranged to allow single handed activation of the biopsy assembly while precluding accidental activation. In one embodiment, a pair of control buttons is provided, one on the front face of the control panel, and another on the back face of the control panel. Biopsy assembly movement may only be activated via simultaneous depression of both buttons. Other mechanisms for affirming operator intent may be substituted herein without affecting the scope of the invention.


According to one aspect of the invention, mechanical stops may be introduced into the biopsy path to stop automated needle movement at particular points along the path. For example, it may be desirable to switch to manual control of the needle movement, i.e, via knob 33a or 33b when the needle is within a desired range of the target. Or it may be desirable to provide a release brake for slow insertion of the needle into the breast. According to one embodiment, the number and location of mechanical stops is a programmable function which may be tailored to the individual preferences of a user of the system. Suffice it to say that numerous methods for mechanical advancement of the needle, including geared advancements, piston advancements, etc. are envisioned.


Returning now to FIG. 9, at step 95 once the needle has been advanced to the target coordinates, an image may be acquired to verify that, in fact, the needle is positioned at the lesion. As the biopsy needle is out of the view of the x-ray imaging system such image may be obtained without interference. At step 96, when it is verified that the needle is at the target, the tissue may be excised, and the biopsy is complete. Although not explicitly shown in the flow diagram, steps 95 and 96 may be repeated to verify excision of the entire lesion.


Accordingly a biopsy needle assembly has been shown and described. According to another aspect of the invention, a user interface of the acquisition workstation is advantageously augmented with needle biopsy control capabilities, An example of user interface features that may be added to an acquisition workstation for use with the needle biopsy assembly is shown in FIG. 11. The user interface includes menus and/or control buttons or icons which enable the radiologist to control the display and output of information gathered during the biopsy. Targeting tools 110 allow the user to review, modify and delete target information. Image source selectors 120 (including stereotactic, tomosynthesis, scout, mammography, etc.) allow the radiologist to select which images to use for visualization or targeting. Image view selectors 130 allow the radiologist to quickly pull up and view any of the images that may have been acquired during the biopsy. Any of the images may be pulled up in the image window 150. Other information related to the biopsy, such as the type of biopsy device, the relative distances between the target and the compression plate/platform, etc., may also be included on the acquisition workstation. It should be noted that although a particular arrangement of buttons and icons has been shown in the representative view of FIG. 11, the present invention is not limited to any particular representation of such information, and other forms of pull down menus, hyperlinks, icons, buttons, and windows are considered equivalents hereto.


Although the above embodiments have described and illustrated a needle biopsy assembly for obtaining cores when the needle is positioned in a general cranial caudal orientation over the breast, according to one aspect of the invention lateral access to the breast may be achieved through the attachment of a lateral biopsy arm. The ability to perform lateral biopsies is particularly important for patients with thin breasts, as compression may reduce the thickness of the breast to such a degree that the tissue excision port at the distal tip of the biopsy needle cannot be fully inserted into the tissue. FIGS. 12A-12C illustrate various views of an embodiment of the needle biopsy assembly of the present invention that has been augmented with a lateral biopsy arm 200. FIG. 12A is a straight on view of the augmented assembly, FIG. 12B is a perspective view of the augmented assembly while FIG. 12C is a side view of the augmented assembly. The lateral biopsy arm supports the biopsy needle along a line substantially parallel to the detector, thereby permitting lateral excision of breast tissue. In the embodiment of FIGS. 12A-12C, the lateral biopsy arm includes a holster mount plate 210 and a thumb wheel 220. Rotation of the thumb wheel 220 results in manual translation of the needle in the direction indicated generally as X in FIG. 12A. Although manual translation in the X plane is shown, it is appreciated that motorized translation may be achieved by extending control from the guidance module 19 to the holster plate 210.


Targeting of the lesion, which defines how far the needle should move in the X,Y and Z direction is always done assuming that the needle is in a cranial—caudal orientation. According to one aspect of the invention, an electrical connection on the holster mount mounts with a connector on the lateral biopsy arm when the lateral biopsy arm is coupled to the holster mount 13 to enable the guidance module 19 to adjust the guidance coordinate system as appropriate for proper lesion localization.


Accordingly a tilted needle biopsy assembly having numerous advantages has been shown and described. Because the biopsy needle is angled relative to at least one of the detector and the x-ray source, x-ray imaging may be performed during the biopsy procedure without interference by the biopsy device. In addition the angled biopsy needle allows improved access to the axilla and chest wall of the patient. The stereotactic biopsy device of the present invention may be coupled to any x-ray system, whether upright or prone, including but not limited to mammography systems, tomosynthesis systems, and combination mammography/tomosynthesis systems. The system flexibly supports the use of any mode of image capture (i.e., scout, two dimensional mammogram, three-dimensional reconstructed volume) for either or both target visualization and target localization. With such an arrangement, a needle biopsy assembly having improved patient coverage is provided for use with a variety of different x-ray imaging platforms.


Having described exemplary embodiments, it can be appreciated that the examples described above are only illustrative and that other examples also are encompassed within the scope of the appended claims.

Claims
  • 1. A needle biopsy assembly for an imaging system, the needle biopsy assembly comprising: a support structure comprising a first side and a second side;at least one handle extending from the support structure;a coupling mechanism extending from the first side of the support structure, wherein the coupling mechanism is configured to couple the needle biopsy assembly to the imaging system;a guidance module extending from the second side of the support structure;a fixed support arm extending from the guidance module; andan angular support arm coupled to the fixed support arm at an angle offset from a plane defined by the support structure.
  • 2. The needle biopsy assembly of claim 1 further comprising a holster mount, moveably coupled to the angular support arm, the holster mount adapted to support a needle biopsy holster along the angular support arm.
  • 3. The needle biopsy assembly of claim 2 wherein the guidance module further comprises components for controlling a motorized movement of the holster mount along the angular support arm.
  • 4. The needle biopsy assembly of claim 2 further comprising a mechanism for manually advancing the holster mount along the angular support arm.
  • 5. The needle biopsy assembly of claim 2 further comprising a control unit for controlling the guidance module.
  • 6. The needle biopsy assembly of claim 5 wherein the control unit includes a display for displaying information related to the biopsy assembly.
  • 7. The needle biopsy assembly of claim 6 wherein the information is associated with a position of a biopsy device coupled to the angular support arm.
  • 8. The needle biopsy assembly of claim 6 wherein the information includes information associated with a type of biopsy device coupled to the angular support arm.
  • 9. The needle biopsy assembly of claim 5 wherein the display information includes warning information related to the biopsy assembly.
  • 10. The needle biopsy assembly of claim 1 including an adjustment mechanism for adjusting the angle between the fixed support and the angular support arm.
  • 11. The needle biopsy assembly of claim 1 further comprising a needle support coupled to the angular support arm.
  • 12. The needle biopsy assembly of claim 1 further comprising a lateral biopsy arm, couplable to the assembly, for supporting a biopsy needle during lateral biopsies.
  • 13. A needle biopsy assembly for an imaging system, the needle biopsy assembly comprising: a support structure comprising a first side and a second side;a pair of handles extending from the support structure;a fixed support arm extending from the first side of the support structure;an angular support arm extending from the fixed support arm at an angle offset from a plane defined by the support structure;a connector pivotably securing the angular support arm to the fixed support arm;an adjustment mechanism for varying an angle of displacement between the angular support arm and the fixed support arm; anda plurality of hooks extending from the second side of the support structure, wherein the hooks are configured to removably connect the needle biopsy assembly to the imaging system.
  • 14. The needle biopsy assembly of claim 13, further comprising a holster mount movably coupled to the angular support arm.
  • 15. The needle biopsy assembly of claim 14, further comprising an attachment mechanism for securing a biopsy holster to the angular support arm.
  • 16. The needle biopsy assembly of claim 13, further comprising a lateral biopsy arm removably securable to the angular support arm.
  • 17. A needle biopsy assembly for an imaging system, the needle biopsy assembly comprising: a support structure;a first handle extending from a first end of the support structure;a second handle extending from a second end of the support structure;a guidance module secured to the support structure between the first handle and the second handle;a fixed support arm extending from the guidance module;an angular support arm extending from the fixed support arm at an angle offset from a plane defined by the support structure;a display removably positionable to each of the first handle and the second handle; anda coupling mechanism extending from the support structure, wherein the coupling mechanism is configured to couple the needle biopsy assembly to the imaging system.
  • 18. The needle biopsy assembly of claim 17, wherein the angular support arm is pivotably connected to the fixed support arm.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/715,591, now U.S. Pat. No. 10,595,954, filed Mar. 2, 2010; which claims priority pursuant to 35 U.S.C. § 1.119(e) to provisional patent application Ser. No. 61/249,772 filed Oct. 8, 2009, the disclosures of which are hereby incorporated herein by reference in their entireties.

US Referenced Citations (460)
Number Name Date Kind
3502878 Stewart Mar 1970 A
3863073 Wagner Jan 1975 A
3971950 Evans et al. Jul 1976 A
4160906 Daniels Jul 1979 A
4310766 Finkenzeller et al. Jan 1982 A
4496557 Malen et al. Jan 1985 A
4559641 Caugant et al. Dec 1985 A
4706269 Reina et al. Nov 1987 A
4744099 Huettenrauch May 1988 A
4773086 Fujita Sep 1988 A
4773087 Plewes Sep 1988 A
4819258 Kleinman et al. Apr 1989 A
4821727 Levene et al. Apr 1989 A
4907156 Doi et al. Jun 1990 A
4969174 Schied Nov 1990 A
4989227 Tirelli et al. Jan 1991 A
5018176 Romeas et al. May 1991 A
RE33634 Yanaki Jul 1991 E
5029193 Saffer Jul 1991 A
5051904 Griffith Sep 1991 A
5078142 Siczek et al. Jan 1992 A
5099846 Hardy Mar 1992 A
5129911 Siczek et al. Jul 1992 A
5133020 Giger et al. Jul 1992 A
5163075 Lubinsky Nov 1992 A
5164976 Scheid et al. Nov 1992 A
5199056 Darrah Mar 1993 A
5219351 Teubner Jun 1993 A
5240011 Assa Aug 1993 A
5279309 Taylor et al. Jan 1994 A
5280427 Magnusson Jan 1994 A
5289520 Pellegrino et al. Feb 1994 A
5343390 Doi et al. Aug 1994 A
5359637 Webbe Oct 1994 A
5365562 Toker Nov 1994 A
5386447 Siczek Jan 1995 A
5415169 Siczek et al. May 1995 A
5426685 Pellegrino et al. Jun 1995 A
5452367 Bick Sep 1995 A
5491627 Zhang et al. Feb 1996 A
5499097 Ortyn et al. Mar 1996 A
5506877 Niklason et al. Apr 1996 A
5526394 Siczek Jun 1996 A
5539797 Heidsieck et al. Jul 1996 A
5553111 Moore Sep 1996 A
5592562 Rooks Jan 1997 A
5594769 Pellegrino et al. Jan 1997 A
5596200 Sharma Jan 1997 A
5598454 Franetzki Jan 1997 A
5609152 Pellegrino et al. Mar 1997 A
5627869 Andrew et al. May 1997 A
5642433 Lee et al. Jun 1997 A
5642441 Riley et al. Jun 1997 A
5647025 Frost et al. Jul 1997 A
5657362 Giger et al. Aug 1997 A
5668889 Hara Sep 1997 A
5671288 Wilhelm et al. Sep 1997 A
5712890 Spivey Jan 1998 A
5719952 Rooks Feb 1998 A
5735264 Siczek et al. Apr 1998 A
5763871 Ortyn et al. Jun 1998 A
5769086 Ritchart et al. Jun 1998 A
5773832 Sayed et al. Jun 1998 A
5803912 Siczek et al. Sep 1998 A
5818898 Tsukamoto et al. Oct 1998 A
5828722 Ploetz Oct 1998 A
5835079 Shieh Nov 1998 A
5841124 Ortyn et al. Nov 1998 A
5872828 Niklason et al. Feb 1999 A
5875258 Ortyn et al. Feb 1999 A
5878104 Ploetz Mar 1999 A
5878746 Lemelson et al. Mar 1999 A
5896437 Ploetz Apr 1999 A
5941832 Tumey Aug 1999 A
5954650 Saito Sep 1999 A
5986662 Argiro Nov 1999 A
6005907 Ploetz Dec 1999 A
6022325 Siczek et al. Feb 2000 A
6067079 Shieh May 2000 A
6075879 Roehrig et al. Jun 2000 A
6091841 Rogers Jul 2000 A
6101236 Wang et al. Aug 2000 A
6102866 Nields et al. Aug 2000 A
6137527 Abdel-Malek Oct 2000 A
6141398 He Oct 2000 A
6149301 Kautzer et al. Nov 2000 A
6175117 Komardin Jan 2001 B1
6196715 Nambu Mar 2001 B1
6215892 Douglass et al. Apr 2001 B1
6216540 Nelson Apr 2001 B1
6219059 Argiro Apr 2001 B1
6256370 Yavus Apr 2001 B1
6233473 Sheperd May 2001 B1
6243441 Zur Jun 2001 B1
6245028 Furst et al. Jun 2001 B1
6272207 Tang Aug 2001 B1
6289235 Webber et al. Sep 2001 B1
6292530 Yavus Sep 2001 B1
6293282 Lemelson Sep 2001 B1
6327336 Gingold et al. Dec 2001 B1
6327377 Rutenberg et al. Dec 2001 B1
6341156 Baetz Jan 2002 B1
6375352 Hewes Apr 2002 B1
6389104 Bani-Hashemi et al. May 2002 B1
6411836 Patel Jun 2002 B1
6415015 Nicolas Jul 2002 B2
6424332 Powell Jul 2002 B1
6442288 Haerer Aug 2002 B1
6459925 Nields et al. Oct 2002 B1
6463181 Duarte Oct 2002 B2
6468226 McIntyre, IV Oct 2002 B1
6480565 Ning Nov 2002 B1
6501819 Unger et al. Dec 2002 B2
6556655 Chichereau Apr 2003 B1
6574304 Hsieh Jun 2003 B1
6597762 Ferrant Jul 2003 B1
6611575 Alyassin et al. Aug 2003 B1
6620111 Stephens et al. Sep 2003 B2
6626849 Huitema et al. Sep 2003 B2
6633674 Barnes Oct 2003 B1
6638235 Miller et al. Oct 2003 B2
6647092 Eberhard Nov 2003 B2
6650928 Gailly Nov 2003 B1
6683934 Zhao Jan 2004 B1
6744848 Stanton Jun 2004 B2
6748044 Sabol et al. Jun 2004 B2
6751285 Eberhard Jun 2004 B2
6758824 Miller et al. Jul 2004 B1
6813334 Koppe Nov 2004 B2
6882700 Wang Apr 2005 B2
6885724 Li Apr 2005 B2
6901156 Giger et al. May 2005 B2
6912319 Barnes May 2005 B1
6940943 Claus Sep 2005 B2
6978040 Berestov Dec 2005 B2
6987331 Koeppe Jan 2006 B2
6999554 Mertelmeier Feb 2006 B2
7022075 Grunwald et al. Apr 2006 B2
7025725 Dione et al. Apr 2006 B2
7030861 Westerman Apr 2006 B1
7110490 Eberhard Sep 2006 B2
7110502 Tsuji Sep 2006 B2
7117098 Dunlay et al. Oct 2006 B1
7123684 Jing et al. Oct 2006 B2
7127091 OpDeBeek Oct 2006 B2
7142633 Eberhard Nov 2006 B2
7218766 Eberhard May 2007 B2
7245694 Jing et al. Jul 2007 B2
7289825 Fors et al. Oct 2007 B2
7298881 Giger et al. Nov 2007 B2
7315607 Ramsauer Jan 2008 B2
7319735 Defreitas et al. Jan 2008 B2
7323692 Rowlands Jan 2008 B2
7346381 Okerlund et al. Mar 2008 B2
7406150 Minyard et al. Jul 2008 B2
7430272 Jing et al. Sep 2008 B2
7443949 Defreitas et al. Oct 2008 B2
7466795 Eberhard et al. Dec 2008 B2
7577282 Gkanatsios et al. Aug 2009 B2
7606801 Faitelson et al. Oct 2009 B2
7616801 Gkanatsios et al. Nov 2009 B2
7630533 Ruth et al. Dec 2009 B2
7634050 Muller et al. Dec 2009 B2
7640051 Krishnan Dec 2009 B2
7697660 Ning Apr 2010 B2
7702142 Ren et al. Apr 2010 B2
7705830 Westerman et al. Apr 2010 B2
7760924 Ruth et al. Jul 2010 B2
7769219 Zahniser Aug 2010 B2
7787936 Kressy Aug 2010 B2
7809175 Roehrig et al. Oct 2010 B2
7828733 Zhang et al. Nov 2010 B2
7831296 DeFreitas et al. Nov 2010 B2
7869563 DeFreitas Jan 2011 B2
7974924 Holla et al. Jul 2011 B2
7991106 Ren et al. Aug 2011 B2
8044972 Hall et al. Oct 2011 B2
8051386 Rosander et al. Nov 2011 B2
8126226 Bernard et al. Feb 2012 B2
8155421 Ren et al. Apr 2012 B2
8165365 Bernard et al. Apr 2012 B2
8532745 DeFreitas et al. Sep 2013 B2
8571289 Ruth Oct 2013 B2
8594274 Hoernig et al. Nov 2013 B2
8677282 Cragun et al. Mar 2014 B2
8712127 Ren et al. Apr 2014 B2
8897535 Ruth et al. Nov 2014 B2
8983156 Periaswamy et al. Mar 2015 B2
9020579 Smith Apr 2015 B2
9075903 Marshall Jul 2015 B2
9084579 Ren et al. Jul 2015 B2
9119599 Itai Sep 2015 B2
9129362 Jerebko Sep 2015 B2
9289183 Karssemeijer Mar 2016 B2
9451924 Bernard Sep 2016 B2
9456797 Ruth et al. Oct 2016 B2
9478028 Parthasarathy Oct 2016 B2
9589374 Gao Mar 2017 B1
9592019 Sugiyama Mar 2017 B2
9805507 Chen Oct 2017 B2
9808215 Ruth et al. Nov 2017 B2
9811758 Ren et al. Nov 2017 B2
9901309 DeFreitas et al. Feb 2018 B2
10008184 Kreeger et al. Jun 2018 B2
10010302 Ruth et al. Jul 2018 B2
10092358 DeFreitas Oct 2018 B2
10111631 Gkanatsios Oct 2018 B2
10242490 Karssemeijer Mar 2019 B2
10335094 DeFreitas Jul 2019 B2
10357211 Smith Jul 2019 B2
10410417 Chen et al. Sep 2019 B2
10413263 Ruth et al. Sep 2019 B2
10444960 Marshall Oct 2019 B2
10456213 DeFreitas Oct 2019 B2
10573276 Kreeger et al. Feb 2020 B2
10575807 Gkanatsios Mar 2020 B2
10595954 DeFreitas Mar 2020 B2
10624598 Chen Apr 2020 B2
10977863 Chen Apr 2021 B2
10978026 Kreeger Apr 2021 B2
11419565 Gkanatsios Aug 2022 B2
20010038681 Stanton et al. Nov 2001 A1
20010038861 Hsu et al. Nov 2001 A1
20020012450 Tsuji Jan 2002 A1
20020050986 Inoue May 2002 A1
20020075997 Unger et al. Jun 2002 A1
20020113681 Byram Aug 2002 A1
20020122533 Marie et al. Sep 2002 A1
20020188466 Barrette et al. Dec 2002 A1
20020193676 Bodicker Dec 2002 A1
20030007598 Wang Jan 2003 A1
20030018272 Treado et al. Jan 2003 A1
20030026386 Tang Feb 2003 A1
20030048260 Matusis Mar 2003 A1
20030073895 Nields et al. Apr 2003 A1
20030095624 Eberhard et al. May 2003 A1
20030097055 Yanof May 2003 A1
20030128893 Castorina Jul 2003 A1
20030135115 Burdette et al. Jul 2003 A1
20030169847 Karellas Sep 2003 A1
20030194050 Eberhard Oct 2003 A1
20030194121 Eberhard et al. Oct 2003 A1
20030195433 Turovskiy Oct 2003 A1
20030210254 Doan Nov 2003 A1
20030212327 Wang Nov 2003 A1
20030215120 Uppaluri Nov 2003 A1
20040008809 Webber Jan 2004 A1
20040008900 Jabri et al. Jan 2004 A1
20040008901 Avinash Jan 2004 A1
20040036680 Davis Feb 2004 A1
20040047518 Tiana Mar 2004 A1
20040052328 Saboi Mar 2004 A1
20040064037 Smith Apr 2004 A1
20040066884 Claus Apr 2004 A1
20040066904 Eberhard et al. Apr 2004 A1
20040070582 Smith et al. Apr 2004 A1
20040077938 Mark et al. Apr 2004 A1
20040081273 Ning Apr 2004 A1
20040094167 Brady May 2004 A1
20040101095 Jing et al. May 2004 A1
20040109028 Stern et al. Jun 2004 A1
20040109529 Eberhard et al. Jun 2004 A1
20040127789 Ogawa Jul 2004 A1
20040138569 Grunwald Jul 2004 A1
20040171933 Stoller et al. Sep 2004 A1
20040171986 Tremaglio, Jr. et al. Sep 2004 A1
20040267157 Miller et al. Dec 2004 A1
20050047636 Gines et al. Mar 2005 A1
20050049521 Miller et al. Mar 2005 A1
20050063509 Defreitas et al. Mar 2005 A1
20050078797 Danielsson et al. Apr 2005 A1
20050084060 Seppi et al. Apr 2005 A1
20050089205 Kapur Apr 2005 A1
20050105679 Wu et al. May 2005 A1
20050107689 Sasano May 2005 A1
20050111718 MacMahon May 2005 A1
20050113681 DeFreitas et al. May 2005 A1
20050113715 Schwindt et al. May 2005 A1
20050124845 Thomadsen et al. Jun 2005 A1
20050135555 Claus Jun 2005 A1
20050135664 Kaufhold Jun 2005 A1
20050226375 Eberhard Oct 2005 A1
20060009693 Hanover et al. Jan 2006 A1
20060018526 Avinash Jan 2006 A1
20060025680 Jeune-Iomme Feb 2006 A1
20060030784 Miller et al. Feb 2006 A1
20060074288 Kelly et al. Apr 2006 A1
20060098855 Gkanatsios et al. May 2006 A1
20060129062 Nicoson et al. Jun 2006 A1
20060132508 Sadikali Jun 2006 A1
20060155209 Miller et al. Jun 2006 A1
20060147099 Marshall et al. Jul 2006 A1
20060197753 Hotelling Sep 2006 A1
20060210131 Wheeler Sep 2006 A1
20060228012 Masuzawa Oct 2006 A1
20060238546 Handley Oct 2006 A1
20060257009 Wang Nov 2006 A1
20060269040 Mertelmeier Nov 2006 A1
20060291618 Eberhard et al. Dec 2006 A1
20070019846 Bullitt et al. Jan 2007 A1
20070030949 Jing et al. Feb 2007 A1
20070036265 Jing et al. Feb 2007 A1
20070046649 Reiner Mar 2007 A1
20070052700 Wheeler et al. Mar 2007 A1
20070076844 Defreitas et al. Apr 2007 A1
20070114424 Danielsson et al. May 2007 A1
20070118400 Morita et al. May 2007 A1
20070156451 Gering Jul 2007 A1
20070223651 Wagenaar et al. Sep 2007 A1
20070225600 Weibrecht et al. Sep 2007 A1
20070236490 Casteele Oct 2007 A1
20070242800 Jing et al. Oct 2007 A1
20070263765 Wu Nov 2007 A1
20070274585 Zhang et al. Nov 2007 A1
20080019581 Gkanatsios et al. Jan 2008 A1
20080043905 Hassanpourgol Feb 2008 A1
20080045833 DeFreitas et al. Feb 2008 A1
20080101537 Sendai May 2008 A1
20080114614 Mahesh et al. May 2008 A1
20080125643 Huisman May 2008 A1
20080130979 Ren Jun 2008 A1
20080139896 Baumgart Jun 2008 A1
20080152086 Hall Jun 2008 A1
20080165136 Christie et al. Jul 2008 A1
20080187095 Boone et al. Aug 2008 A1
20080198966 Hjarn Aug 2008 A1
20080221479 Ritchie Sep 2008 A1
20080229256 Shibaike Sep 2008 A1
20080240533 Piron et al. Oct 2008 A1
20080297482 Weiss Dec 2008 A1
20090003519 DeFreitas Jan 2009 A1
20090005668 West et al. Jan 2009 A1
20090010384 Jing et al. Jan 2009 A1
20090034684 Bernard Feb 2009 A1
20090037821 O'Neal et al. Feb 2009 A1
20090079705 Sizelove et al. Mar 2009 A1
20090080594 Brooks et al. Mar 2009 A1
20090080602 Brooks et al. Mar 2009 A1
20090080604 Shores et al. Mar 2009 A1
20090080752 Ruth Mar 2009 A1
20090080765 Bernard et al. Mar 2009 A1
20090087067 Khorasani Apr 2009 A1
20090123052 Ruth May 2009 A1
20090129644 Daw et al. May 2009 A1
20090135997 Defreitas et al. May 2009 A1
20090138280 Morita et al. May 2009 A1
20090143674 Nields Jun 2009 A1
20090167702 Nurmi Jul 2009 A1
20090171244 Ning Jul 2009 A1
20090238424 Arakita Sep 2009 A1
20090259958 Ban Oct 2009 A1
20090268865 Ren et al. Oct 2009 A1
20090278812 Yasutake Nov 2009 A1
20090296882 Gkanatsios et al. Dec 2009 A1
20090304147 Jing et al. Dec 2009 A1
20100034348 Yu Feb 2010 A1
20100049046 Peiffer Feb 2010 A1
20100054400 Ren et al. Mar 2010 A1
20100079405 Bernstein Apr 2010 A1
20100086188 Ruth et al. Apr 2010 A1
20100088346 Urness et al. Apr 2010 A1
20100098214 Star-Lack et al. Apr 2010 A1
20100105879 Katayose et al. Apr 2010 A1
20100121178 Krishnan May 2010 A1
20100131294 Venon May 2010 A1
20100131482 Linthicum et al. May 2010 A1
20100135558 Ruth et al. Jun 2010 A1
20100152570 Navab Jun 2010 A1
20100166267 Zhang Jul 2010 A1
20100195882 Ren et al. Aug 2010 A1
20100208037 Sendai Aug 2010 A1
20100231522 Li Sep 2010 A1
20100246909 Blum Sep 2010 A1
20100259561 Forutanpour et al. Oct 2010 A1
20100259645 Kaplan Oct 2010 A1
20100260316 Stein et al. Oct 2010 A1
20100280375 Zhang Nov 2010 A1
20100293500 Cragun Nov 2010 A1
20110018817 Kryze Jan 2011 A1
20110019891 Puong Jan 2011 A1
20110054944 Sandberg et al. Mar 2011 A1
20110069808 Defreitas et al. Mar 2011 A1
20110069906 Park Mar 2011 A1
20110087132 DeFreitas et al. Apr 2011 A1
20110105879 Masumoto May 2011 A1
20110109650 Kreeger May 2011 A1
20110110576 Kreeger May 2011 A1
20110150447 Li Jun 2011 A1
20110163939 Tam et al. Jul 2011 A1
20110178389 Kumar et al. Jul 2011 A1
20110182402 Partain Jul 2011 A1
20110234630 Batman et al. Sep 2011 A1
20110237927 Brooks et al. Sep 2011 A1
20110242092 Kashiwagi Oct 2011 A1
20110310126 Georgiev et al. Dec 2011 A1
20120014504 Jang Jan 2012 A1
20120014578 Karssemeijer Jan 2012 A1
20120069951 Toba Mar 2012 A1
20120131488 Karlsson et al. May 2012 A1
20120133600 Marshall May 2012 A1
20120133601 Marshall May 2012 A1
20120134464 Hoernig et al. May 2012 A1
20120148151 Hamada Jun 2012 A1
20120189092 Jerebko Jul 2012 A1
20120194425 Buelow Aug 2012 A1
20120238870 Smith et al. Sep 2012 A1
20120293511 Mertelmeier Nov 2012 A1
20130022165 Jang Jan 2013 A1
20130044861 Muller Feb 2013 A1
20130059758 Haick Mar 2013 A1
20130108138 Nakayama May 2013 A1
20130121569 Yadav May 2013 A1
20130121618 Yadav May 2013 A1
20130202168 Jerebko Aug 2013 A1
20130259193 Packard Oct 2013 A1
20140033126 Kreeger Jan 2014 A1
20140035811 Guehring Feb 2014 A1
20140064444 Oh Mar 2014 A1
20140073913 DeFreitas et al. Mar 2014 A1
20140219534 Wiemker et al. Aug 2014 A1
20140219548 Wels Aug 2014 A1
20140327702 Kreeger et al. Nov 2014 A1
20140328517 Gluncic Nov 2014 A1
20150052471 Chen Feb 2015 A1
20150061582 Smith Apr 2015 A1
20150238148 Georgescu Aug 2015 A1
20150302146 Marshall Oct 2015 A1
20150309712 Marshall Oct 2015 A1
20150317538 Ren et al. Nov 2015 A1
20150331995 Zhao Nov 2015 A1
20160000399 Halmann et al. Jan 2016 A1
20160022364 DeFreitas et al. Jan 2016 A1
20160051215 Chen Feb 2016 A1
20160078645 Abdurahman Mar 2016 A1
20160140749 Erhard May 2016 A1
20160228034 Gluncic Aug 2016 A1
20160235380 Smith Aug 2016 A1
20160367210 Gkanatsios Dec 2016 A1
20170071562 Suzuki Mar 2017 A1
20170262737 Rabinovich Sep 2017 A1
20180047211 Chen et al. Feb 2018 A1
20180137385 Ren May 2018 A1
20180144244 Masoud May 2018 A1
20180256118 DeFreitas Sep 2018 A1
20190015173 DeFreitas Jan 2019 A1
20190043456 Kreeger Feb 2019 A1
20190290221 Smith Sep 2019 A1
20200046303 DeFreitas Feb 2020 A1
20200093562 DeFreitas Mar 2020 A1
20200184262 Chui Jun 2020 A1
20200253573 Gkanatsios Aug 2020 A1
20200345320 Chen Nov 2020 A1
20210100518 Chui Apr 2021 A1
20210113167 Chui Apr 2021 A1
20210118199 Chui Apr 2021 A1
20220005277 Chen Jan 2022 A1
20220013089 Kreeger Jan 2022 A1
20220192615 Chui Jun 2022 A1
20230053489 Kreeger Feb 2023 A1
20230054121 Chui Feb 2023 A1
Foreign Referenced Citations (99)
Number Date Country
2014339982 Apr 2015 AU
1846622 Oct 2006 CN
202161328 Mar 2012 CN
102429678 May 2012 CN
107440730 Dec 2017 CN
102010009295 Aug 2011 DE
102011087127 May 2013 DE
775467 May 1997 EP
982001 Mar 2000 EP
1428473 Jun 2004 EP
2236085 Jun 2010 EP
2215600 Aug 2010 EP
2301432 Mar 2011 EP
2491863 Aug 2012 EP
1986548 Jan 2013 EP
2656789 Oct 2013 EP
2823464 Jan 2015 EP
2823765 Jan 2015 EP
3060132 Apr 2019 EP
H09-198490 Jul 1997 JP
H09-238934 Sep 1997 JP
H10-33523 Feb 1998 JP
2000-200340 Jul 2000 JP
2002-282248 Oct 2002 JP
2003-189179 Jul 2003 JP
2003-199737 Jul 2003 JP
2003-531516 Oct 2003 JP
2004254742 Sep 2004 JP
2006-519634 Aug 2006 JP
2006-312026 Nov 2006 JP
2007-130487 May 2007 JP
2007-330334 Dec 2007 JP
2007-536968 Dec 2007 JP
2008-068032 Mar 2008 JP
2009-034503 Feb 2009 JP
2009-522005 Jun 2009 JP
2009-526618 Jul 2009 JP
2009-207545 Sep 2009 JP
2010-137004 Jun 2010 JP
2011-110175 Jun 2011 JP
2012501750 Jan 2012 JP
2012011255 Jan 2012 JP
2012-061196 Mar 2012 JP
2013-244211 Dec 2013 JP
2014-507250 Mar 2014 JP
2014-534042 Dec 2014 JP
2015-506794 Mar 2015 JP
2015-144632 Aug 2015 JP
2016-198197 Dec 2015 JP
10-2015-0010515 Jan 2015 KR
10-2017-0062839 Jun 2017 KR
9005485 May 1990 WO
9317620 Sep 1993 WO
9406352 Mar 1994 WO
199700649 Jan 1997 WO
199816903 Apr 1998 WO
0051484 Sep 2000 WO
2003020114 Mar 2003 WO
2005051197 Jun 2005 WO
2005110230 Nov 2005 WO
2005110230 Nov 2005 WO
2005112767 Dec 2005 WO
2005112767 Dec 2005 WO
2006055830 May 2006 WO
2006058160 Jun 2006 WO
2007095330 Aug 2007 WO
08014670 Feb 2008 WO
2008014670 Feb 2008 WO
2008047270 Apr 2008 WO
2008054436 May 2008 WO
2009026587 Feb 2009 WO
2010028208 Mar 2010 WO
2010059920 May 2010 WO
2011008239 Jan 2011 WO
2011043838 Apr 2011 WO
2011065950 Jun 2011 WO
2011073864 Jun 2011 WO
2011091300 Jul 2011 WO
2012001572 Jan 2012 WO
2012068373 May 2012 WO
2012063653 May 2012 WO
2012112627 Aug 2012 WO
2012122399 Sep 2012 WO
2013001439 Jan 2013 WO
2013035026 Mar 2013 WO
2013078476 May 2013 WO
2013123091 Aug 2013 WO
2014080215 May 2014 WO
2014149554 Sep 2014 WO
2014207080 Dec 2014 WO
2015061582 Apr 2015 WO
2015066650 May 2015 WO
2015130916 Sep 2015 WO
2016103094 Jun 2016 WO
2016184746 Nov 2016 WO
2018183548 Oct 2018 WO
2018183549 Oct 2018 WO
2018183550 Oct 2018 WO
2018236565 Dec 2018 WO
Non-Patent Literature Citations (95)
Entry
Bushberg, Jerrold et al., “The Essential Physics of Medical Imaging”, 3rd ed., In: “The Essential Physics of Medical Imaging, Third Edition”, Dec. 28, 2011, Lippincott & Wilkins, Philadelphia, PA, USA, XP05579051, pp. 270-272.
Dromain, Clarisse et al., “Dual-energy contrast-enhanced digital mammography: initial clinical results”, European Radiology, Sep. 14, 2010, vol. 21, pp. 565-574.
Reynolds, April, “Stereotactic Breast Biopsy: A Review”, Radiologic Technology, vol. 80, No. 5, Jun. 1, 2009, pp. 447M-464M, XP055790574.
“Filtered Back Projection”, (NYGREN), published May 8, 2007, URL: http://web.archive.org/web/19991010131715/http://www.owlnet.rice.edu/˜elec539/Projects97/cult/node2.html, 2 pgs.
Berg WA et al., “Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer”, JAMA 299:2151-2163, 2008.
Canadian Office Action in Application 2829349, dated Oct. 15, 2018, 4 pages.
Carton AK, et al., “Dual-energy contrast-enhanced digital breast tomosynthesis—a feasibility study”, BR J Radiol. Apr. 2010;83 (988):344-50.
Chen SC, et al., “Initial clinical experience with contrast-enhanced digital breast tomosynthesis”, Acad Radio. Feb. 2007 14(2):229-38.
Chinese 2nd Office Action in Application 201480058064.5, dated Jul. 16, 2019, 5 pgs.
Diekmann F., et al., “Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement”, Invest Radiol 2005; 40:397-404.
Dromain C., et al., “Contrast enhanced spectral mammography: a multi-reader study”, RSNA 2010, 96th Scientific Assembly and Scientific Meeting.
Dromain C., et al., “Contrast-enhanced digital mammography”, Eur J Radiol. 2009; 69:34-42.
EP Extended Search Report dated Jul. 18, 2014 in EP App 12754521.8, 7 pages.
European Communication in Application 10707751.3, dated Oct. 4, 2018, 5 pages. (corresponding to 0.0020USU1 matter).
European Communication in Application 10707751.3, dated Aug. 7, 2019, 6 pages.
European Extended Search Report for European Patent Application No. 14770362.3 dated Sep. 28, 2016, 8 pgs.
European Extended Search Report in Application 14855181.5, dated May 15, 2017, 7 pages.
European extended Search Report in Application 18153706.9, dated Jun. 1, 2018, 8 pages.
European Mar. 23, 2009 European Search Report in connection with counterpart European patent Application No. 07750818.
European Office Action in Application 10707751.3, dated Feb. 19, 2018, 5 pgs.
Freiherr G., “Breast tomosynthesis trials show promise”, Diagnostic Imaging—San Francisco 2005, V27; N4:42-48.
Giger, M. et al., “An “Intelligent” Workstation for Computer-aided Diagnosis”, RadioGraphics, (1993), 13(3): 647-656.
Giger, M. et al., “Development of a “smart” workstation for use in mammography”, Proceedings of SPIE, (1991), 45: 101-103.
Hologic, “Lorad StereoLoc II” Operator's Manual 9-500-0261, Rev. 005, 2004, 78 pgs.
Hologic, Inc., 510(k) Summary, prepared Nov. 28, 2010, for Affirm Breast Biopsy Guidance System Special 510(k) Premarket Notification, 5 pages.
Hologic, Inc., 510(k) Summary, prepared Aug. 14, 2012, for Affirm Breast Biopsy Guidance System Special 510(k) Premarket Notification, 5 pages.
ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection.
Japanese Notice of Final Rejection in Application 2016-526115, dated Jun. 24, 2019, 5 pages.
Jochelson M., et al, Bilateral, RSNA 2010, 96th Scientific Assembly and Scientific Meeting.
Jong, RA, et al., Contrast-enhanced digital mammography: initial clinical experience. Radiology 2003; 228:842-850.
Kopans, et.al. Will tomosynthesis replace conventional mammography? Plenary Session SFN08: RSNA 2005.
Lehman CD, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356:1295-1303.
Lewin JM, et al., Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology 2003; 229:261-268.
Lindfors KK, et al., Dedicated breast CT: initial clinical experience. Radiology 2008; 246(3): 725-733.
Niklason, L., et al., Digital tomosynthesis in breast imaging. Radiology. Nov. 1997; 205(2):399-406.
Observations by Third Party, Remarks concerning European patent application No. 10707751.3 according to Article 115 EPC, dated Apr. 24, 2014, 8 pgs.
PCT Feb. 20, 2008 International Search Report and Written Opinion in connection with corresponding International patent application No. PCT/US2007/04006, 7 pgs.
PCT International Preliminary Report on Patentability in International Application PCT/US2014/061994, dated Apr. 26, 2016, 5 pages.
PCT International Search Report and Written Opinion in Application PCT/US2010/025873, dated Aug. 2, 2010, 19 pgs.
PCT International Search Report in Application PCT/US2014/026164, dated Jul. 28, 2014, 1 page.
PCT International Written Report for International Application PCT/US2014/026164, dated Jul. 28, 2014, 12 pgs.
PCT Written Opinion in International Application PCT/US2014/061994, dated Jan. 22, 2015, 4 pages.
PCT/US12/28334 International Search Report and Written Opinion, dated Jul. 5, 2012.
Poplack SP, et al, Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenology Sep. 2007 189(3):616-23.
Prionas ND, et al., Contrast-enhanced dedicated breast CT: initial clinical experience. Radiology. Sep. 2010 256(3):714-723.
Rafferty E. et al. Assessing Radiologist Performance Using Combined Full-Field Digital Mammography and Breast Tomosynthesis Versus Full-Field Digital Mammography Alone: Results . . . presented at 2007 Radiological Society of North America meeting, Chicago IL.
Shrading, Simone et al., “Digital Breast Tomosynthesis-guided Vacuum-assisted Breast Biopsy: Initial Experiences and Comparison with Prone Stereotactic Vacuum-assisted Biopsy”, the Department of Diagnostic and Interventional Radiology, Univ. of Aachen, Germany, published Nov. 12, 2014, 10 pgs.
Smith, A., Full field breast tomosynthesis. Radiol Manage. Sep.-Oct. 2005; 27(5):25-31.
Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. New England Journal of Medicine 1991; 324:1-8.
Weidner N, The importance of tumor angiogenesis: the evidence continues to grow. Am J Clin Pathol. Nov. 2004 122(5):696-703.
European Communication of a Notice of Opposition in Application 10707751.3, dated Sep. 13, 2021, 23 pages.
Burbank, Fred, “Stereotactic Breast Biopsy: Its History, Its Present, and Its Future”, published in 1996 at the Southeastern Surgical Congress, 24 pages. (Reference labeled D9 in 0020 Opposition).
Georgian-Smith, Dianne, et al., “Stereotactic Biopsy of the Breast Using an Upright Unit, a Vacuum-Suction Needle, and a Lateral Arm-Support System”, 2001, at the American Roentgen Ray Society meeting, 8 pages. (Reference labeled D10 in 0020 Opposition).
Fischer Imaging Corp, Mammotest Plus manual on minimally invasive breast biopsy system, 2002, 8 pages.
Fischer Imaging Corporation, Installation Manual, MammoTest Family of Breast Biopsy Systems, 86683G, 86684G, P-55957-IM, Issue 1, Revision 3, Jul. 2005, 98 pages.
Fischer Imaging Corporation, Operator Manual, MammoTest Family of Breast Biopsy Systems, 86683G, 86684G, P-55956-OM, Issue 1, Revision 6, Sep. 2005, 258 pages.
Koechli, Ossi R., “Available Sterotactic Systems for Breast Biopsy”, Renzo Brun del Re (Ed.), Minimally Invasive Breast Biopsies, Recent Results in Cancer Research 173:105-113; Springer-Verlag, 2009.
Samani, A. et al., “Biomechanical 3-D Finite Element Modeling of the Human Breast Using MRI Data”, 2001, IEEE Transactions on Medical Imaging, vol. 20, No. 4, pp. 271-279.
Yin, H.M., et al., “Image Parser: a tool for finite element generation from three-dimensional medical images”, BioMedical Engineering Online. 3:31, pp. 1-9, Oct. 1, 2004.
Sakic et al., “Mammogram synthesis using a 3D simulation. I. breast tissue model and image acquisition simulation” Medical Physics. 29, pp. 2131-2139 (2002).
Wodajo, Felasfa, MD, “Now Playing: Radiology Images from Your Hospital PACS on your iPad,” Mar. 17, 2010; web site: http://www.imedicalapps.com/2010/03/now-playing-radiology-images-from-your-hospital-pacs-on-your-ipad/, accessed on Nov. 3, 2011 (3 pages).
Pathmanathan et al., “Predicting tumour location by simulating large deformations of the breast using a 3D finite element model and nonlinear elasticity”, Medical Image Computing and Computer-Assisted Intervention, pp. 217-224, vol. 3217 (2004).
Al Sallab et al., “Self Learning Machines Using Deep Networks”, Soft Computing and Pattern Recognition (SoCPaR), 2011 Int'l. Conference of IEEE, Oct. 14, 2011, pp. 21-26.
Caroline, B.E. et al., “Computer aided detection of masses in digital breast tomosynthesis: A review”, 2012 International Conference on Emerging Trends in Science, Engineering and Technology (INCOSET), Tiruchirappalli, 2012, pp. 186-191.
Ertas, M. et al., “2D versus 3D total variation minimization in digital breast tomosynthesis”, 2015 IEEE International Conference on Imaging Systems and Techniques (IST), Macau, 2015, pp. 1-4.
Ghiassi, M. et al., “A Dynamic Architecture for Artificial Networks”, Neurocomputing, vol. 63, Aug. 20, 2004, pp. 397-413.
Chan, Heang-Ping et al., “ROC Study of the effect of stereoscopic imaging on assessment of breast lesions,” Medical Physics, vol. 32, No. 4, Apr. 2005, 1001-1009.
Lilja, Mikko, “Fast and accurate voxel projection technique in free-form cone-beam geometry with application to algebraic reconstruction,” Applies Sciences on Biomedical and Communication Technologies, 2008, Isabel '08, first international symposium on, IEEE, Piscataway, NJ, Oct. 25, 2008.
Pediconi, “Color-coded automated signal intensity-curve for detection and characterization of breast lesions: Preliminary evaluation of new software for MR-based breast imaging,” International Congress Series 1281 (2005) 1081-1086.
EFilm Mobile HD by Merge Healthcare, web site: http://itunes.apple.com/bw/app/efilm-mobile-hd/id405261243?mt=8, accessed on Nov. 3, 2011 (2 pages).
EFilm Solutions, eFilm Workstation (tm) 3.4, website: http://estore.merge.com/na/estore/content.aspx?productID=405, accessed on Nov. 3, 2011 (2 pages).
Diekmann, Felix et al., “Thick Slices from Tomosynthesis Data Sets: Phantom Study for the Evaluation of Different Algorithms”, Journal of Digital Imaging, Springer, vol. 22, No. 5, Oct. 23, 2007, pp. 519-526.
E. Shaw de Paredes et al., “Interventional Breast Procedure”, published Sep./Oct. 1998 in Curr Probl Diagn Radiol, pp. 138-184.
Van Schie, Guido, et al., “Mass detection in reconstructed digital breast tomosynthesis volumes with a computer-aided detection system trained on 2D mammograms”, Med. Phys. 40(4), Apr. 2013, 41902-1-41902-11.
Van Schie, Guido, et al., “Generating Synthetic Mammograms from Reconstructed Tomosynthesis Volumes”, IEEE Transactions on Medical Imaging, vol. 32, No. 12, Dec. 2013, 2322-2331.
Conner, Peter, “Breast Response to Menopausal Hormone Therapy—Aspects on Proliferation, apoptosis and Mammographic Density”, 2007 Annals of Medicine, 39;1, 28-41.
Glick, Stephen J., “Breast CT”, Annual Rev. Biomed. Eng., 2007, 9;501-26.
Metheany, Kathrine G. et al., “Characterizing anatomical variability in breast CT images”, Oct. 2008, Med. Phys. 35 (10); 4685-4694.
Dromain, Clarisse, et al., “Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography”, AJR: 187, Nov. 2006, 16 pages.
Zhao, Bo, et al., “Imaging performance of an amorphous selenium digital mammography detector in a breast tomosynthesis system”, May 2008, Med. Phys 35(5); 1978-1987.
Mahesh, Mahadevappa, “AAPM/RSNA Physics Tutorial for Residents—Digital Mammography: An Overview”, Nov.-Dec. 2004, vol. 24, No. 6, 1747-1760.
Zhang, Yiheng et al., “A comparative study of limited-angle cone-beam reconstruction methods for breast tomosythesis”, Med Phys., Oct. 2006, 33(10): 3781-3795.
Sechopoulos, et al., “Glandular radiation dose in tomosynthesis of the breast using tungsten targets”, Journal of Applied Clinical Medical Physics, vol. 8, No. 4, Fall 2008, 161-171.
Wen, Junhai et al., “A study on truncated cone-beam sampling strategies for 3D mammography”, 2004, IEEE, 3200-3204.
Ijaz, Umer Zeeshan, et al., “Mammography phantom studies using 3D electrical impedance tomography with numerical forward solver”, Frontiers in the Convergence of Bioscience and Information Technologies 2007, 379-383.
Kao, Tzu-Jen et al., “Regional admittivity spectra with tomosynthesis images for breast cancer detection”, Proc. Of the 29th Annual Int'l. Conf. of the IEEE EMBS, Aug. 23-26, 2007, 4142-4145.
Varjonen, Mari, “Three-Dimensional Digital Breast Tomosynthesis in the Early Diagnosis and Detection of Breast Cancer”, IWDM 2006, LNCS 4046, 152-159.
Taghibakhsh, f. et al., “High dynamic range 2-TFT amplified pixel sensor architecture for digital mammography tomosynthesis”, IET Circuits Devices Syst., 2007, 1(10, pp. 87-92.
Chan, Heang-Ping et al., “Computer-aided detection system for breast masses on digital tomosynthesis mammograms: Preliminary Experience”, Radiology, Dec. 2005, 1075-1080.
“Supersonic to feature Aixplorer Ultimate at ECR”, AuntiMinnie.com, 3 pages (Feb. 2018).
Kopans, Daniel B., “Breast Imaging”, 3rd Edition, Lippincott Williams and Wilkins, published Nov. 2, 2006, pp. 960-967.
Williams, Mark B. et al., “Optimization of exposure parameters in full field digital mammography”, Medical Physics 35, 2414 (May 20, 2008); doi: 10.1118/1.2912177, pp. 2414-2423.
Elbakri, Idris A. et al., “Automatic exposure control for a slot scannong full field digital mammagraphy system”, Med. Phys. Sep. 2005; 32(9):2763-2770, Abstract only.
Feng, Steve Si Jia, et al., “Clinical digital breast tomosynthesis system: Dosimetric Characterization”, Radiology, Apr. 2012, 263(1); pp. 35-42.
European Transmittal of Decision and Summons to attend oral proceedings in EP Application 10707751.3, dated Mar. 8, 2022, 15 pages.
Related Publications (1)
Number Date Country
20200205928 A1 Jul 2020 US
Provisional Applications (1)
Number Date Country
61249772 Oct 2009 US
Continuations (1)
Number Date Country
Parent 12715591 Mar 2010 US
Child 16809355 US